Evaluation of respiratory alkalosis

Diseases

Summary

Respiratory alkalosis is a systemic acid-base disorder characterized by a primary reduction in arterial partial pressure of carbon dioxide (PaCO₂), which produces an elevation in pH above 7.45, and consequent decrease in bicarbonate (HCO₃-) concentration, as buffering mechanisms.[1] It may occur as a simple primary disorder, a sole respiratory abnormality in which a decrease in PaCO₂ results from excess alveolar CO₂ excretion relative to CO₂ production. Respiratory alkalosis may also occur as compensation for an underlying process, such as metabolic acidosis, or as a separate component of a mixed acid-base disorder, in which case the PaCO₂, HCO₃-, and pH are determined by the combined effects of the underlying acid-base disorders.[2]

Respiratory alkalosis can be classified into three categories:

as a component of disease processes
accidentally induced
deliberately induced (therapeutic).[3]

Accidental respiratory alkalosis develops as a consequence of inappropriate settings of mechanical ventilation, or associated with extracorporeal membrane oxygenation.[3] Therapeutic respiratory alkalosis or hypocapnia has been applied to temporarily treat intracranial hypertension or neonatal pulmonary artery hypertension.[4] [5]

Epidemiology

Respiratory alkalosis is common. Two large studies of inpatients from the US evaluating arterial blood samples showed a respiratory alkalosis prevalence of 22.5% to 44.7%.[6] [7] Because arterial blood was withdrawn at various times in the patients' hospital course, these figures probably represent instances of respiratory alkalosis from disparate categories. In an Italian study, arterial blood samples obtained from 110 consecutive patients at the time of hospital admission demonstrated respiratory alkalosis in 24%.[8]

The occurrence of accidentally induced respiratory alkalosis may be inferred from a retrospective study of intubated patients with burns (146 people) who received mechanical ventilation for aeromedical transport. The frequency of respiratory alkalosis was 19%, in which 39% of patients received volume-assist control and 17% of patients on intermittent mandatory ventilation experienced hypocapnia.[9] [10] In volume-assist control (or volume control), patients may receive either controlled or assisted breaths. When the patient triggers the ventilator, a breath of identical duration and magnitude is delivered from the machine. In intermittent mandatory ventilation, machine breaths are interposed among the patient's spontaneous breaths. Yet another study reported that the majority of patients undergoing cardiopulmonary bypass (86 people) were hypocapnic during the rewarming phase, and that this disorder persisted in many until the time of intensive care unit arrival.[11] The study did not report the actual frequency of hypocapnia.[11]

Therapeutic respiratory alkalosis or hypocapnia has traditionally been applied to temporarily treat intracranial hypertension.[4] However, the benefit of therapeutic hypocapnia remains unproven and it should be limited to life-threatening elevated intracranial pressure.[12] [13] Its application in either elevated intracranial pressure or neonatal pulmonary hypertension has not been shown to improve survival, and therefore its use should be carefully limited.[3] [5] [14] With the availability of nitric oxide and other vasodilators, therapeutic hypocapnia application in neonatal pulmonary hypertension will be expected to decline.[15] [16]

Physiology

In respiratory alkalosis, initial suppression of the respiratory center and reduction in plasma bicarbonate concentration attenuate the rise in pH. Excess CO₂ excretion (alveolar hyperventilation) and the resulting low arterial PaCO₂ (hypocapnia) inhibits the respiratory centre through a negative feedback loop. The systemic effect of the initial reduction in PaCO₂ can be described by the modified Henderson-Hasselbalch equation as follows:

(H+)=24(PaCO₂/HCO₃-)

The decrease in PaCO₂ reduces the PaCO₂/HCO₃- ratio, hence reducing the H+ concentration, which results in alkalemia. The decrease in PCO₂ also leads to a reduced rate of H+ secretion and increased rate of bicarbonate excretion by the renal tubules as an intracellular buffering mechanism. Within the renal tubular cells, CO₂, under the influence of carbonic anhydrase enzyme, combines with H₂O to form carbonic acid (H₂CO₃), which then dissociates into HCO3- and H+. Alkalemia inhibits carbonic anhydrase activity, resulting in reduced H+ secretion into the renal tubule.[17] HCO₃- reabsorption is dependent on combining with H+ to form carbonic acid, which later dissociates into H₂O and CO₂. Owing to the reduced H+ concentration in the renal tubule, there is inadequate H+ concentration to react with the filtered HCO₃-. HCO₃- reabsorption decreases, resulting in reduced plasma HCO₃- concentration and attenuation of pH.

The physicochemical (Stewart or strong ion difference) approach to acid-base analysis similarly shows that acute hyperventilation and fall in PaCO₂ slowly lead to hyperchloremic renal compensation. The hyperchloremia is related to excretion of filtered sodium and potassium with bicarbonate as hydrogen secretion decreases in proximal and distal tubules. As the plasma strong ion difference decreases, the plasma bicarbonate concentration decreases, resulting in the return of serum pH toward normal. Both the traditional and the Stewart approaches illustrate that renal compensation is caused by a change in the ratio of PaCO₂ to bicarbonate (see above modified Henderson-Hasselbalch equation).[18]

Respiratory alkalosis can manifest as acute or chronic. Acute respiratory alkalosis occurs from the onset of hypocapnia for up to 6 hours.[1] Chronic respiratory alkalosis with renal compensatory mechanisms begins 6 hours after the onset of hypocapnia and becomes complete within 2 to 5 days.[1] [19] [20] In acute respiratory alkalosis, the relationship between the decrease in serum HCO₃- and the decrease in PaCO₂ can be expressed as:

change in HCO₃- (mEq/L ) = 0.1 x change in PaCO₂ (mmHg)

where the decrease in HCO₃- is from a normal value of 24 mEq/L and the decrease in PaCO₂ is from a normal value of 40 mmHg. For instance, an acute decrease in PaCO₂ of 20 mmHg will result in serum HCO₃- of approximately 22 mEq/L : that is, a decrease of 2 mEq/L (0.1 x 20) from the normal value of serum HCO₃- of 24 mEq/L. Notable deviation of serum HCO₃- concentration from the predicted value suggests acid-base disorder other than isolated acute respiratory alkalosis.

In chronic respiratory alkalosis, serum HCO₃- is further reduced owing to suppression of renal tubular H+ secretion and HCO₃- reabsorption. Thus, the magnitude of the decrease in H+ concentration is attenuated to a greater extent than in the acute stage. In chronic respiratory alkalosis, the relation between the decrease in serum HCO₃- and the decrease in PaCO₂ can be expressed as:[21] [22]

change in HCO₃- (mEq/L) = 0.4 x change in PaCO₂ (mmHg)

In this instance, a persistent decrease in PaCO₂ of 20 mmHg will decrease serum HCO₃- by 8 mEq/L from its normal value of 24 mEq/L, resulting in serum HCO₃- of 16 mEq/L. In patients with isolated chronic respiratory alkalosis, serum HCO₃- rarely decreases below 12 to 14 mEq/L.[20]

Respiratory alkalosis leads to increased serum lactate by mildly increasing lactate production and by decreasing lactate clearance.[23] [24] Interestingly, in one small study, induced respiratory alkalosis in trained athletes by voluntary hyperventilation has been shown to attenuate performance decline as measured by peak and mean power output in repeated sprinting. This is thought to be due to retardation of the acidosis caused by exercise-induced lactic acidosis.[25]

Respiratory alkalosis also alters electrolyte homeostasis, separate from its renal compensatory mechanisms.

Potassium

Initially, hyperkalemia occurs owing to hyperventilation-induced augmentation of alpha-adrenergic activity. Afterwards, hypokalemia ensues owing to transcellular shift, decreased renal reabsorption, and bicarbonaturia. Bicarbonaturia increases renal potassium excretion.[26] [27] Hypokalemia is usually mild but can be severe in pregnant women due to high circulating progesterone levels causing hyperventilation and respiratory alkalosis. One case report described a patient with respiratory alkalosis-induced hypokalemia leading to flaccid paralysis.[19]

Phosphate

In the acute phase, hypophosphatemia may be related to increased cellular uptake.[28] [29] Conversely, the chronic phase is associated with hyperphosphatemia together with hypocalcemia due to parathyroid hormone resistance.[30]

Bronchoconstriction is a prominent manifestation of physiologic changes in the lung.[31] [32] [33] Effects on the pulmonary artery, and pH-related changes in respiratory alkalosis, can induce pulmonary arterial vasodilation, which is used commonly to treat neonatal persistent pulmonary hypertension.[5] [34] Tachycardia is also consistent with physiologic changes inherent in respiratory alkalosis and is related to increased sympathetic activity and to hypokalemia.[26] [35] Chest pain may occur through coronary vasospasm or decreased myocardial oxygen delivery owing to increased O₂ affinity to hemoglobin.[36] Data also suggest that respiratory alkalosis significantly decreased in vivo microcirculatory flow as measured by reflectance confocal microscopy during states of sustained hypocapnia (PaCO₂ 20.9 ± 2.9). This was seen without concomitant decrease in cardiac output.[37] Ventricular and atrial arrhythmias have also been reported in acute and chronic respiratory alkalosis.[38] [39] [40]

Gastrointestinal and hepatic symptoms are seen in acute (but not in chronic) respiratory alkalosis. Acute respiratory alkalosis produces nausea, vomiting, and increased gastrointestinal motility.[41] The mechanism for increased colonic tone is dependent on the presence of hypocapnia (and not eucapnic hyperventilation), which seems to have a direct effect on colonic smooth muscle.[42] Peripheral and central nervous system (CNS) effects of hypocapnia occur at a threshold of PaCO₂ <20 mmHg.[43] Symptoms include vertigo, dizziness, anxiety, euphoria, clumsiness, forgetfulness, hallucinations, and seizure.[44] Unilateral somatic symptoms have also been reported, including partial seizures, migraines, or stroke-like symptoms. CNS symptoms are initiated by changes in pH (rather than changes in PaCO₂), which reduce cerebral blood flow, causing cerebral ischemia that ultimately accounts for neurologic symptoms.[45] Peripheral manifestations include tetany and paresthesias. These neurologic manifestations are mediated by hyperventilation-induced increased neural excitability caused by hypocalcemia and, possibly, hypophosphatemia.[45] [46] [47]

In determining whether a second primary acid-base process coexists with respiratory alkalosis, the pH is a key factor, because compensatory mechanisms do not restore the pH entirely. Significant deviations of HCO₃- concentration predicted in acute, or in chronic, respiratory alkalosis indicate a second primary acid-base process. Note that serum HCO₃- rarely decreases below 12 to 14 mEq/L in isolated chronic respiratory alkalosis and values below this suggest an independent component of metabolic acidosis.[48] If hypocapnia occurs with acidemia, a primary respiratory alkalosis is present, if the degree of hypocapnia is greater than would be expected in response to the coexisting metabolic acidosis.

Citations

Key Articles

Foster GT, Varizi ND, Sassoon CS. Respiratory alkalosis. Respir Care. 2001 Apr;46(4):384-91.[Abstract]
Laffey JG, Kavanagh BP. Hypocapnia. N Engl J Med. 2002 Jul 4;347(1):43-53.[Abstract]
Berend K, de Vries AP, Gans RO. Physiological approach to assessment of acid-base disturbances. N Engl J Med. 2014 Oct 9;371(15):1434-45.[Abstract]

Referenced Articles

1. Arbus GS, Herbert LA, Levesque PR, et al. Characterization and clinical application of the "significance band" for acute respiratory alkalosis. N Engl J Med. 1969 Jan 16;280(3):117-23.[Abstract]
2. Foster GT, Varizi ND, Sassoon CS. Respiratory alkalosis. Respir Care. 2001 Apr;46(4):384-91.[Abstract]
3. Laffey JG, Kavanagh BP. Hypocapnia. N Engl J Med. 2002 Jul 4;347(1):43-53.[Abstract]
4. Allen CH, Ward JD. An evidence-based approach to management of increased intracranial pressure. Crit Care Clin. 1998 Jul;14(3):485-95.[Abstract]
5. Walsh-Sukys MC, Tyson JE, Wright LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics. 2000 Jan;105(1 Pt 1):14-20.[Abstract]
6. Hodgkin JE, Soeprono FF, Chan DM. Incidence of metabolic alkalemia in hospitalized patients. Crit Care Med. 1980 Dec;8(12):725-8.[Abstract]
7. Mazzara JT, Ayres SM, Grace WJ. Extreme hypocapnia in the critically ill patient. Am J Med. 1974 Apr;56(4):450-6.[Abstract]
8. Palange P, Carlone S, Galassetti P, et al. Incidence of acid-base and electrolyte disturbances in a general hospital: a study of 110 consecutive admissions. Recenti Prog Med. 1990 Dec;81(12):788-91.[Abstract]
9. Barillo DJ, Dickerson EE, Cioffi WG, et al. Pressure-controlled ventilation for the long-range aeromedical transport of patients with burns. J Burn Care Rehabil. 1997 May-Jun;18(3):200-5.[Abstract]
10. Hooper RG, Browning M. Acid-base changes and ventilator mode during maintenance ventilation. Crit Care Med. 1985 Jan;13(1):44-5.[Abstract]
11. Millar SM, Alston RP, Andrews PJ, et al. Cerebral hypoperfusion in immediate postoperative period following coronary artery bypass grafting, heart valve, and abdominal aortic surgery. Br J Anesth. 2001 Aug;87(2):229-36.[Abstract][Full Text]
12. Curley G, Kavanagh BP, Laffey JG. Hypocapnia and the injured brain: more harm than benefit. Crit Care Med. 2010 May;38(5):1348-59.[Abstract]
13. Badjatia N, Carney N, Crocco TJ, et al; Brain Trauma Foundation; BTF Center for Guidelines Management. Guidelines for prehospital management of traumatic brain injury 2nd edition. Prehosp Emerg Care. 2008;12(suppl 1):S1-52.[Abstract]
14. Rusnak M, Janciak I, Majdan M, et al. Severe traumatic brain injury in Austria VI: effects of guideline-based management. Wien Klin Wochenschr. 2007 Feb;119(1-2):64-71.[Abstract]
15. Latini G, Del Vecchio A, De Felice C, et al. Persistent pulmonary hypertension of the newborn: therapeutical approach. Mini Rev Med Chem. 2008 Dec;8(14):1507-13.[Abstract]
16. Kelly LE, Ohlsson A, Shah PS. Sildenafil for pulmonary hypertension in neonates. Cochrane Database Syst Rev. 2017 Aug 4;(8):CD005494.[Abstract][Full Text]
17. Jacobson HR. Effects of CO2 and acetazolamide on bicarbonate and fluid transport in rabbit proximal tubules. Am J Physiol. 1981 Jan;240(1):F54-62.[Abstract]
18. Seifter JL. Integration of acid-base and electrolyte disorders. N Engl J Med. 2014 Nov 6;371(19):1821-31.[Abstract]
19. Santra G, Paul R, Das S, et al. Hyperventilation of pregnancy presenting with flaccid quadriparesis due to hypokalaemia secondary to respiratory alkalosis. J Assoc Physicians India. 2014 Jun;62(6):536-8.[Full Text]
20. Berend K, de Vries AP, Gans RO. Physiological approach to assessment of acid-base disturbances. N Engl J Med. 2014 Oct 9;371(15):1434-45.[Abstract]
21. Gennari FJ, Goldstein MB, Schwartz WB. The nature of the renal adaptation to chronic hypocapnia. J Clin Invest. 1972 Jul;51(7):1722-30.[Abstract][Full Text]
22. Krapf R, Beeler I, Hertner D, et al. Chronic respiratory alkalosis: the effect of sustained hyperventilation on renal regulation of acid-base equilibrium. N Engl J Med. 1991 May 16;324(20):1394-401.[Abstract]
23. Eldridge F, Salzer J. Effect of respiratory alkalosis on blood lactate and pyruvate in humans. J Appl Physiol. 1967 Mar;22(3):461-8.[Abstract]
24. Druml W, Grimm G, Laggner AN, et al. Lactic acid kinetics in respiratory acidosis. Crit Care Med. 1991 Sep;19(9):1120-4.[Abstract]
25. Sakamoto A, Naito H, Chow CM. Hyperventilation as a strategy for improved repeated sprint performance. J Strength Cond Res. 2014 Apr;28(4):1119-26.[Abstract]
26. Krapf R, Caduff P, Wagdi P, et al. Plasma potassium response to acute respiratory alkalosis. Kidney Int. 1995 Jan;47(1):217-24.[Abstract]
27. Sanchez MG, Finlayson DC. Dynamics of serum potassium change during acute respiratory alkalosis. Can Anaesth Soc J. 1978 Nov;25(6):495-8.[Abstract]
28. Brautbar N, Leibovici H, Massry SG. On the mechanism of hypophosphatemia during acute hyperventilation: evidence for increased muscle glycolysis. Miner Electrolyte Metab. 1983 Jan-Feb;9(1):45-50.[Abstract]
29. Hoppe A, Metler M, Berndt TJ. Effect of respiratory alkalosis on renal phosphate excretion. Am J Physiol. 1982 Nov;243(5):F471-5.[Abstract]
30. Krapf R, Jaeger P, Hulter HN. Chronic respiratory alkalosis induces renal PTH-resistance, hyperphosphatemia, and hypocalcemia in humans. Kidney Int. 1992 Sep;42(3):727-34.[Abstract]
31. Jamison JP, Glover PJ, Wallace WF. Comparison of the effects of inhaled ipratropium bromide and salbutamol on the bronchoconstrictor response to hypocapnic hyperventilation in normal subjects. Thorax. 1987 Oct;42(10):809-14.[Abstract][Full Text]
32. Rodriguez-Roisin R. Gas exchange abnormalities in asthma. Lung. 1990;168(Suppl):599-605.[Abstract]
33. Bayindir O, Akpinar B, Ozbek U, et al. The hazardous effects of alveolar hypocapnia on lung mechanics during weaning from cardiopulmonary bypass. Perfusion. 2000 Jan;15(1):27-31.[Abstract]
34. Fike CD, Hansen TN. The effect of alkalosis on hypoxia-induced vasoconstriction in lungs of newborn rabbits. Pediatr Res. 1989 Apr;25(4):383-8.[Abstract]
35. Samuelsson RG, Nagy G. Effects of respiratory alkalosis and acidosis on myocardial excitation. Acta Physiol Scand. 1976 Jun;97(2):158-65.[Abstract]
36. Neill WA, Hattenhauer M. Impairment of myocardial O2 supply due to hyperventilation. Circulation. 1975 Nov;52(5):854-8.[Abstract][Full Text]
37. Morel J, Gergelé L, Dominé A, et al. The venous-arterial difference in CO2 should be interpreted with caution in case of respiratory alkalosis in healthy volunteers. J Clin Monit Comput. 2017 Aug;31(4):701-7.[Abstract]
38. Wildenthal K, Fuller DS, Shapiro W. Paroxysmal atrial arrhythmias induced by hyperventilation. Am J Cardiol. 1968 Mar;21(3):436-41.[Abstract]
39. Hisano K, Matsuguchi T, Ootsubo H, et al. Hyperventilation-induced variant angina with ventricular tachycardia. Am Heart J. 1984 Aug;108(2):423-5.[Abstract]
40. Brown EB Jr, Miller F. Ventricular fibrillation following a rapid fall in alveolar carbon dioxide concentration. Am J Physiol.1952 Apr;169(1):56-60.[Abstract]
41. Bharucha AE, Camilleri M, Ford MJ, et al. Hyperventilation alters colonic motor and sensory function: effects and mechanisms in humans. Gastroenterology. 1996 Aug;111(2):368-77.[Abstract]
42. Ford MJ, Camelleri MJ, Hanson RB, et al. Hyperventilation, central autonomic control, and colonic tone in humans. Gut. 1995 Oct;37(4):499-504.[Abstract][Full Text]
43. Rafferty GF, Saisch GN, Gardner WN. Relation of hypocapnic symptoms to rate of fall of end-tidal PCO2 in normal subjects. Respir Med. 1992 Jul;86(4):335-40.[Abstract]
44. Perkin GD, Joseph R. Neurological manifestations of the hyperventilation syndrome. J R Soc Med. 1986 Aug;79(8):448-50.[Abstract][Full Text]
45. Gardner WN. The pathophysiology of hyperventilation disorders. Chest. 1996 Feb;109(2):516-34.[Abstract]
46. Macefield G, Burke D. Paraesthesiae and tetany induced by voluntary hyperventilation: increased excitability of human cutaneous and motor axons. Brain. 1991 Feb;114 ( Pt 1B):527-40.[Abstract]
47. Edmondson JW, Brashear RE, Li TK. Tetany: quantitative interrelationships between calcium and alkalosis. Am J Physiol. 1975 Apr;228(4):1082-6.[Abstract]
48. Kaehny WD. Respiratory acid-base disorders. Med Clin North Am. 1983 Jul;67(4):915-28.[Abstract]
49. Caruana-Montaldo B, Gleeson K, Zwillich CW. The control of breathing in clinical practice. Chest. 2000 Jan;117(1):205-25.[Abstract]
50. Grocott MP, Martin DS, Levett DZ, et al. Arterial blood gases and oxygen content in climbers on Mount Everest. N Engl J Med. 2009 Jan 8;360(2):140-9.[Abstract][Full Text]
51. Samaja M, Mariani C, Prestini A, et al. Acid-base balance and O2 transport at high altitude. Acta Physiol Scand. 1997 Mar;159(3):249-56.[Abstract]
52. Fan JL, Burgess KR, Basnyat R, et al. Influence of high altitude on cerebrovascular and ventilatory responsiveness to CO2. J Physiol. 2010 Feb 1;588(Pt 3):539-49.[Abstract][Full Text]
53. Domino KB, Lu Y, Eisenstein BL, et al. Hypocapnia worsens arterial blood oxygenation and increases VA/Q heterogeneity in canine pulmonary edema. Anesthesiology. 1993 Jan;78(1):91-9.[Abstract]
54. Laffey JG, Engelberts D, Kavanagh BP. Injurious effects of hypocapnic alkalosis in the isolated lung. Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):399-405.[Abstract][Full Text]
55. Fujimori K, Satoh M, Arakawa M. Ventilatory response to continuous incremental changes in respiratory resistance in patients with mild asthma. Chest. 1996 Jun;109(6):1525-31.[Abstract]
56. van den Elshout FJ, van Herwaarden CL, Folgering HT. Effects of hypercapnia and hypocapnia on respiratory resistance in normal and asthmatic subjects. Thorax. 1991 Jan;46(1):28-32.[Abstract][Full Text]
57. Javaheri S, Sicilian L. Lung function, breathing pattern, and gas exchange in interstitial lung disease. Thorax. 1992 Feb;47(2):93-7.[Abstract][Full Text]
58. Horrobin D, Cholmondeley HG. High altitude pulmonary oedema: pathophysiology and recommendations for prevention and treatment. East Afr Med J. 1972 Apr;49(4):327-31.[Abstract]
59. Trimble C, Smith DE, Rosenthal MH, et al. Pathophysiologic role of hypocarbia in post-traumatic pulmonary insufficiency. Am J Surg. 1971 Nov;122(5):633-8.[Abstract]
60. Mortelliti MP, Manning HL. Acute respiratory distress syndrome. Am Fam Physician. 2002 May 1;65(9):1823-30.[Abstract][Full Text]
61. Sahn SA, Heffner JE. Spontaneous pneumothorax. N Engl J Med. 2000 Mar 23;342(12):868-74.[Abstract]
62. Subotic D, Mandaric D, Gajic M, et al. Uncertainties in the current understanding of gas exchange in spontaneous pneumothorax: effective lung ventilation may persist in a smaller-sized pneumothorax. Med Hypotheses. 2005;64(6):1144-9.[Abstract]
63. Manganelli D, Palla A, Donnamaria V, et al. Clinical features of pulmonary embolism: doubts and certainties. Chest. 1995;107(suppl):25S-32S.[Abstract]
64. Kuo PC, Plotkin JS, Johnson LB, et al. Distinctive clinical features of portopulmonary hypertension. Chest. 1997 Oct;112(4):980-6.[Abstract]
65. Jones PW, Huszczuk A, Wasserman K. Cardiac output as a controller of ventilation through changes in right ventricular load. J Appl Physiol. 1982 Jul;53(1):218-24.[Abstract]
66. Milsom WK, Sadig T. Interaction between norepinephrine and hypoxia on carotid body chemoreception in rabbits. J Appl Physiol. 1983 Dec;55(6):1893-8.[Abstract]
67. Davoodi M, Rezvankhah B, Gohari Moghadam K, et al. The prevalence and predicting factors of pulmonary thromboembolism in patients with exacerbated chronic obstructive pulmonary disease. Adv Respir Med. 2018 Aug 15 [epub ahead of print].[Abstract][Full Text]
68. Androgue HJ, Madias NE. Management of life-threatening acid-base disorders: second of two parts. N Engl J Med. 1998 Jan 8;338(2):107-11.[Abstract]
69. Bernstein D, Tripodi J. Fulminant hepatic failure. Crit Care Clin. 1998 Apr;14(2):181-97.[Abstract]
70. Brashear RE. Hyperventilation syndrome. Lung. 1983;161(5):257-73.[Abstract]
71. Musso CG, Juarez R, Glassock RJ. Water, electrolyte, acid-base, and trace elements alterations in cirrhotic patients. Int Urol Nephrol. 2018 Jan;50(1):81-9.[Abstract]
72. Nevin M, Colchester AC, Adams S, et al. Evidence for involvement of hypocapnia and hypoperfusion in aetiology of neurologic deficit after cardiopulmonary bypass. Lancet. 1987 Dec 26;2(8574):1493-5.[Abstract]
73. Graziani LJ, Gringlas M, Baumgart S. Cerebrovascular complications and neurodevelopmental sequelae of neonatal ECMO. Clin Perinatol. 1997 Sep;24(3):655-75.[Abstract]
74. Nazaroğlu H, Ozmen CA, Akay HO, et al. 64-MDCT pulmonary angiography and CT venography in the diagnosis of thromboembolic disease. Am J Roentgenol. 2009 Mar;192(3):654-61.[Abstract]
75. Blair E. Hypocapnia and gram-negative bacteremic shock. Am J Surg. 1970 Apr;119(4):433-9.[Abstract]
76. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med. 2003 Apr;31(4):1250-6.[Abstract]
77. Nystad D, Salvesen R, Nielsen EW. Brain stem encephalitis with central neurogenic hyperventilation. J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):107-8.[Abstract]
78. Sears MR, O'Donoghue JM, Fisher HK, et al. Effect of experimental pneumococcal meningitis on respiration and circulation in the rabbit. J Clin Invest. 1974 Jul;54(1):18-23.[Abstract][Full Text]
79. Hannart B. Pickett CK, Moore LG. Effects of estrogen and progesterone on carotid body neural output responsiveness to hypoxia. J Appl Physiol. 1990 May;68(5):1909-16.[Abstract]
80. Tenholder MF, South-Paul JE. Dyspnea in pregnancy. Chest. 1989 Aug;96(2):381-8.[Abstract]
81. Wise RA, Polito AJ, Krishnan V. Respiratory physiologic changes in pregnancy. Immunol Allergy Clin N Am. 2006 Feb;26(1):1-12.[Abstract]
82. Damas-Mora J, Davies L, Taylor W, et al. Menstrual respiratory changes and symptoms. Br J Psychiatry. 1980 May;136:492-7.[Abstract]
83. Orr-Walker BJ, Horne AM, Evans MC, et al. Hormone replacement therapy causes a respiratory alkalosis in normal postmenopausal women. J Clin Endocrinol Metab. 1999 Jun;84(6):1997-2001.[Abstract][Full Text]
84. White MD. Components and mechanisms of thermal hyperpnea. J Appl Physiol. 2006 Aug;101(2):655-63.[Abstract][Full Text]
85. Tsuji B, Filingeri D, Honda Y, et al. Effect of hypocapnia on the sensitivity of hyperthermic hyperventilation and the cerebrovascular response in resting heated humans. J Appl Physiol (1985). 2018 Jan 1;124(1):225-33.[Abstract][Full Text]
86. Davis DP, Idris AH, Sise MJ, et al. Early ventilation and outcome in patients with moderate to severe traumatic brain injury. Crit Care Med. 2006 Apr;34(4):1202-8.[Abstract]
87. Ogoh S, Nakahara H, Ainslie PN, et al. The effect of oxygen on dynamic cerebral autoregulation: critical role of hypocapnia. J Appl Physiol. 2010 Mar;108(3):538-43.[Abstract]
88. Pappas A, Shankaran S, Laptook AR, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy. J Pediatr. 2011 May;158(5):752-8.e1.[Abstract][Full Text]
89. Esnault P, Roubin J, Cardinale M, et al. Spontaneous hyperventilation in severe traumatic brain injury: incidence and association with poor neurological outcome. Neurocrit Care. 2019 Apr;30(2):405-13.[Abstract][Full Text]
90. Sachan D, Goyal S. Association of hypocapnia in children with febrile seizures. J Pediatr Neurosci. 2018 Oct-Dec;13(4):388-91.[Abstract][Full Text]
91. Tarulli AW, Lim C, Bui JD, et al. Central neurogenic hyperventilation: a case report and discussion of pathophysiology. Arch Neurol. 2005 Oct;62(10):1632-4.[Abstract][Full Text]
92. Lee MC, Klassen AC, Heaney LM, et al. Respiratory rate and pattern disturbances in acute brain stem infarction. Stroke. 1976 Jul-Aug;7(4):382-5.[Abstract][Full Text]
93. Scialdone AM. Thalamic hemorrhage imitating hyperventilation. Ann Emerg Med. 1990 Jul;19(7):817-9.[Abstract]
94. Badr MS. Central sleep apnea. Prim Care Clin Office Pract. 2005 Jun;32(2):361-74, vi.[Abstract]
95. Sung H, Sohn J, Kim J, et al. Acute respiratory alkalosis occurring after endoscopic third ventriculostomy: a case report. Korean J Anesthesiol. 2010;59(Suppl):S194-96.[Abstract][Full Text]
96. Solin P, Roebuck T, Johns DP, et al. Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Resp Crit Care Med. 2000 Dec;162(6):2194-200.[Abstract][Full Text]
97. Xie A, Rutherford R, Rankin F, et al. Hypocapnia and increased ventilatory responsiveness in patients with idiopathic central sleep apnea. Am J Resp Crit Care Med. 1995 Dec;152(6 Pt 1):1950-5.[Abstract]
98. Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med. 1999 Oct;160(4):1101-6.[Abstract][Full Text]
99. Sankri-Tarbichi AG, Rowley JA, Badr MS. Expiratory pharyngeal narrowing during central hypocapnic hypopnea. Am J Respir Crit Care Med. 2009 Feb 15;179(4):313-9.[Abstract]
100. Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017 Jan 1;80(1):6-15.[Abstract][Full Text]
101. Moser KM, Luchsinger PC, Adamson JS, et al. Respiratory stimulation with intravenous doxapram in respiratory failure: a double-blind co-operative study. N Engl J Med. 1973 Mar 1;288(9):427-31.[Abstract]
102. Irwin GR Jr. Cerebrospinal fluid pH and respiratory rate in bacterial meningitis. Dis Nerv Syst. 1972 Apr;33(4):276-9.[Abstract]
103. Sugiura M, Shibata K, Saito S, et al. Levofloxacin-associated encephalopathy with severe hyperventilation. Intern Med. 2019 May 15;58(10):1495-99.[Abstract][Full Text]
104. Hornsveld HK, Garssen B, Dop MJ, et al. Double-blind placebo-controlled study of the hyperventilation provocation test and the validity of the hyperventilation syndrome. Lancet. 1996 Jul 20;348(9021):154-8.[Abstract]
105. Brat K, Stastna N, Merta Z, et al. Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome. PLoS One. 2019;14(4):e0215997.[Abstract][Full Text]
106. Zöphel K, Bacher-Stier C, Pinkert J, et al. Ventilation/perfusion lung scintigraphy: what is still needed? A review considering technetium-99m-labeled macro-aggregates of albumin. Ann Nucl Med. 2009 Jan;23(1):1-16.[Abstract]
107. Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. 2021 Dec;160(6):e545-e608.[Abstract]
108. Agnelli G, Becattini C. Acute pulmonary embolism. N Engl J Med. 2010 Jul 15;363(3):266-74.[Abstract]
109. Leigh-Smith S, Harris T. Tension pneumothorax - time for a re-think? Emerg Med J. 2005 Jan;22(1):8-16.[Abstract][Full Text]
110. Yarmus L, Feller-Kopman D. Pneumothorax in the critically ill patient. Chest. 2012 Apr;141(4):1098-1105.[Abstract]
111. Alrajhi K, Woo MY, Vaillancourt C. Test characteristics of ultrasonography for the detection of pneumothorax: a systematic review and meta-analysis. Chest. 2012 Mar;141(3):703-8.[Abstract]
112. Alrajab S, Youssef AM, Akkus NI, et al. Pleural ultrasonography versus chest radiography for the diagnosis of pneumothorax: review of the literature and meta-analysis. Crit Care. 2013 Sep 23;17(5):R208.[Abstract][Full Text]
113. Saver JL, Fonarow GC, Smith EE, et al. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA. 2013 Jun 19;309(23):2480-8.[Abstract][Full Text]
114. Baringer JR. Herpes simplex infections of the nervous system. Neurol Clin. 2008 Aug;26(3):657-74,[Abstract]
115. Chaudhuri A, Martinez-Martin P, Kennedy PG, et al. EFNS guideline on the management of community-acquired bacterial meningitis: report of an EFNS task force on acute bacterial meningitis in older children and adults. Eur J Neurol. 2008 Jul;15(7):649-59.[Abstract][Full Text]
116. Ringleb PA, Schellinger PD, Schranz C, et al. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful? Stroke. 2002 May;33(5):1437-41.[Abstract][Full Text]
117. Tylera KL. Neurological infections: advances in therapy, outcome, and prediction. Lancet Neurol. 2009 Jan;8(1):19-21.[Abstract]
118. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10.[Abstract][Full Text]
119. National Institute for Health and Care Excellence. Sepsis: recognition, diagnosis and early management. Jan 2024 [internet publication].[Full Text]
120. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.[Full Text]
121. Royal College of Physicians. National Early Warning Score (NEWS) 2. December 2017 [internet publication].[Full Text]
122. American College of Emergency Physicians (ACEP) Expert Panel on Sepsis. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. [internet publication].[Full Text]
123. Academy of Medical Royal Colleges. Statement on the initial antimicrobial treatment of sepsis. May 2022 [internet publication].[Full Text]
124. Surviving Sepsis Campaign. Hour-1 bundle: initial resuscitation for sepsis and septic shock. 2019 [internet publication].[Full Text]
125. O'Malley GF. Emergency department management of the salicylate-poisoned patient. Emerg Med Clin North Am. 2007 May;25(2):333-46;[Abstract]
126. Done AK. Aspirin overdosage: incidence, diagnosis, and management. Pediatrics. 1978;62(2 suppl):890S-897S.[Abstract]
127. Kulig K. Salicylate intoxication: is the Done nomogram reliable? [Comment in AACT] Clinical Toxicology UPDATE. 1990;3:2-3.
128. Kozaci N, Güngör F, Oguzhan Ay M, et al. Can venous blood gas values be used instead of arterial blood gas values in respiratory alkalosis? Turk J Biochem. 2014;39:113-8.[Full Text]
129. Schrauben SJ, Negoianu D, Costa C, et al. Accuracy of acid-base diagnoses using the central venous blood gas in the medical intensive care unit. Nephron. 2018;139(4):293-98.[Abstract][Full Text]
130. Stein PD, Hull RD, Patel KC, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. 2004 Apr 20;140(8):589-602.[Abstract]
131. McConnell MV, Solomon SD, Rayan ME, et al. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol. 1996 Aug 15;78(4):469-73.[Abstract]